Skip to main content
. 2022 Sep 12;2022(9):CD011376. doi: 10.1002/14651858.CD011376.pub3

Rooney 2020.

Methods Randomised controlled feasibility trial
Participants Inclusion criteria: adults aged ≥ 18 years diagnosed with a primary brain tumour; ≥ 3 months since radiotherapy or chemotherapy (or both); clinically and radiologically stable; self‐reported fatigue > 4 on Brief Fatigue Inventory
Exclusion criteria: inability to give informed consent; clinically unstable; radiological progression; significant cognitive or sensory impairment
Number randomised: 46
Follow‐up: after interventions and at 16 weeks
Setting: 4 centres across the UK
Interventions 2 treatment arms and 1 self‐guided support arm, of 16 weeks
Arm I 'Health Coaching' schedule
Participants received an information leaflet and 'Health Coaching', which involved an individualised programme based on physical measurements and lifestyle information. Participants wore an activity monitoring device and recorded information in a diary. Participants were offered 5 × 45‐minute Health Coaching sessions (delivered remotely or in person) focused on setting personal goals to change lifestyle factors contributing to fatigue.
Arm II 'Health Coaching plus Patient Activation' schedule
Participants received the same intervention as in arm I plus Patient Activation. Participants were offered 2 × 1‐hour Patient Activation sessions, delivered by a trained coach, focused on improving their approach to managing fatigue.
Arm III control schedule
Participants were given fatigue management information alongside treatment as usual.
Outcomes Feasibility (participant recruitment and retention, acceptability, manageability)
Fatigue (Brief Fatigue Inventory)
Depression (Hospital Anxiety and Depression Scale)
Quality of Life (Psychological Outcome Profiles)
Notes Data not yet published